Travere Therapeutics (TVTX) Enterprise Value (2012 - 2026)
Travere Therapeutics (TVTX) reported Enterprise Value of $5.23 billion for Q2 2026, up 320.8% from $1.24 billion a year earlier and up 96.2% from the prior quarter.
Powered by 
Analysis
Travere Therapeutics (TVTX) Enterprise Value (2012 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Travere Therapeutics' Enterprise Value came in at $4.95 billion, up 355.5% year-over-year; for FY2025, it came in at $3.38 billion, up 130.8% from FY2024.
- Enterprise Value has a five-year compound annual growth rate of 20.4% (FY2020 to FY2025).
- By year, Enterprise Value came in at $1.46 billion in FY2024 (+136.5%), $619.37 million in FY2023 (-52.0%), $1.29 billion in FY2022 (-27.3%) and $1.77 billion in FY2021 (+32.5%).
- The Q2 2026 figure ranks as the highest quarterly Enterprise Value in data going back to Q3 2012.
- Year over year, Enterprise Value has now increased in each of the last eight quarters, with growth averaging 143.1% over the last eight quarters.
- The high point for year-over-year Enterprise Value in five years was Q2 2026 (growth of 320.8%); the low point was Q1 2024 (a decline of 64.1%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $2.67 billion (Q1 2026), $3.38 billion (Q4 2025) and $2.03 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Travere Therapeutics | 5.80 Bn | 5.40 Bn | 167.41 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.23 Bn |
| Mar 31, 2026 | 2.67 Bn |
| Dec 31, 2025 | 3.38 Bn |
| Sep 30, 2025 | 2.03 Bn |
| Jun 30, 2025 | 1.24 Bn |
| Mar 31, 2025 | 1.53 Bn |
| Dec 31, 2024 | 1.46 Bn |
| Sep 30, 2024 | 1.05 Bn |
| Jun 30, 2024 | 596.18 Mn |
| Mar 31, 2024 | 543.55 Mn |
| Dec 31, 2023 | 619.37 Mn |
| Sep 30, 2023 | 527.25 Mn |
| Jun 30, 2023 | 1.08 Bn |
| Mar 31, 2023 | 1.52 Bn |
| Dec 31, 2022 | 1.29 Bn |
| Sep 30, 2022 | 1.43 Bn |
| Jun 30, 2022 | 1.37 Bn |
| Mar 31, 2022 | 1.38 Bn |
| Dec 31, 2021 | 1.77 Bn |
| Sep 30, 2021 | 1.33 Bn |
API Access
Travere Therapeutics Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=TVTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "TVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=TVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();